Tony Ifeanyichukwu Ezenna (born 21 April 1957) is a Nigerian businessman and philanthropist. He was the founder of Orange Drugs Nigeria Limited, a company that specializes in the distribution of pharmaceutical and beauty products from Indonesia, Germany, Italy, and the United States to Nigeria.
BACKGROUND
Ezenna was born in Port Harcourt, River State, Nigeria, where he grew up before moving to Onitsha. He attended St. David primary school in Owerre Akokwa, followed by Christ the King College, Onitsha for his high school education. He later paused his education due to financial hardship and joined his father’s business.
He is married to Elizabeth Ezenna and is a devout Christian.
At Nigerian Books of Record, we keep track of record breakers, impact makers, and change agents. We aim to document, celebrate, and honor the remarkable achievements and excellent records of people.
By honoring new generations of game-changers and sharing their authentic stories, we aim to break boundaries, entertain, inspire, and inform the world.
Books of Record will always strive to encourage, find, and share the uniqueness in every achiever who has distinguished themselves through hard work in every professional calling of life.
Always visit this platform for the latest updates on any of our inductions. Send us an email for suggestions on how we can serve you better or suggestions on the next NBR Hall of Famer.
Advertise with us here.
Please, follow Nigerian Books of Record on Facebook, Instagram, and Twitter.
vykřiknout a říct, že mě opravdu baví číst vaše příspěvky na blogu.
how to get cytotec pills Equally importantly is raising awareness of the fact that the path to parenthood is not easy for so many people, which will hopefully lead to more sensitivity from those who have been fortunate enough not to have experienced struggles themselves
Administer the drug subcutaneously is correct buy priligy reddit One surprising finding that resulted from the cloning and expression of the mineralocorticoid receptor was that it had equal affinity for glucocorticoids and mineralocorticoids
Great article! The depth of analysis is impressive. For those wanting more information, visit: LEARN MORE. Looking forward to the community’s thoughts!